Skip to main content
. 2009 Jun 27;59(1):113–124. doi: 10.1007/s00262-009-0730-7

Fig. 8.

Fig. 8

Hsd17b12114T peptide-based DC vaccines protects mice against Meth A challenge. Groups of three mice each were immunized with 2 × 105 DC pulsed with10 μg/ml of the indicated peptides and challenged 14 days after the last immunization with 2.5 × 105 Meth A sarcoma. Tumor measurements (MTA ± MSE) were taken on the indicated days. Bar indicates vaccines that induced significant tumor inhibition. A representative experiment is shown